...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >DOES PRE-STROKE INHIBITION OF THE RENIN- ANGIOTENSIN SYSTEM REDUCE STROKE SEVERITY?
【24h】

DOES PRE-STROKE INHIBITION OF THE RENIN- ANGIOTENSIN SYSTEM REDUCE STROKE SEVERITY?

机译:预先抑制肾素-血管紧张素系统会降低中风的严重性吗?

获取原文
获取原文并翻译 | 示例

摘要

Background: There is evidence that angiotensin converting enzyme inhibitors (ACEIs) can decrease the risk of stroke. However, it is unclear whether ACEI use prior to stroke provides an additional neuroprotective effect resulting in reduced severity and improved survival.Aim: To assess whether pre-stroke use of ACEIs and angiotensin receptor blockers (ARBs) is associated with reduced stroke severity and reduced 28-day mortality.Methods: We ascertained all strokes occurring in a geographically defined population in Melbourne, Australia during a 24-month period from May 1997. Pre-stroke use of ACEIs and ARBs was obtained from medical records. Stroke severity was dichotomized according to a National Institutes of Health Stroke Scale score <8 (less severe) and >8 (severe).
机译:背景:有证据表明血管紧张素转化酶抑制剂(ACEIs)可以降低中风的风险。然而,尚不清楚卒中前使用ACEI是否会提供额外的神经保护作用,从而导致严重程度降低和存活率的改善。目的:评估卒中前使用ACEI和血管紧张素受体阻滞剂(ARB)是否与卒中严重程度的降低和降低有关方法:我们确定了自1997年5月起的24个月内澳大利亚墨尔本地区特定人群中发生的所有中风。ACEI和ARB的中风前使用来自医疗记录。根据美国国立卫生研究院卒中量表评分将卒中严重程度二等分(<8(严重程度较轻)和> 8(严重))。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号